Community Health Worker Nutrition Self-Management Support for Cardio-Kidney-Metabolic Health (INTEGRATE-CHW)
Integrating Tailored Medical Nutrition Therapy and Community Health Worker Support to Advance Cardio-Kidney-Metabolic Health
This study tests whether adding CHW support to usual nutrition care helps adults with type 2 diabetes, hypertension, or chronic kidney disease manage their diet and health. At Caridad Center, a free clinic in Palm Beach County, Florida, usual care includes medical nutrition therapy from a registered dietitian and medically tailored groceries. Many patients find it hard to keep up dietary changes because of limited nutrition knowledge, cooking skills, food costs, and cultural fit.
Two hundred adults will be randomly assigned to usual care or usual care plus INTEGRATE-CHW, a 12-week program of six sessions with a trained CHW. In each session the participant selects one or two goals from the dietitian's plan and builds an action plan with the CHW. The dietitian remains responsible for the nutrition plan. The study will compare nutrition self-efficacy, nutrition literacy, diet quality, food security, and clinical measures between groups at baseline and Week 12. It will also evaluate how well the program fits into routine clinic care.
Studienübersicht
Status
Status
Bedingungen
Bedingungen
Intervention / Behandlung
Intervention / Behandlung
Detaillierte Beschreibung
Dietitian-led MNT and medically tailored food programs improve diet quality and food security during active participation, but these gains often diminish once food delivery or counseling ends. Sustaining improvement requires ongoing behavioral reinforcement and self-management support that help patients adapt nutrition guidance to their cultural and household routines. This trial tests whether CHWs embedded in the dietitian's workflow can provide that reinforcement within routine care at a safety-net clinic.
The intervention is guided by Social Cognitive Theory, the Corbin and Strauss self-management framework, and Lorig and Holman's self-management skills. Self-efficacy serves as the central behavioral mechanism of change, operationalized through confidence-based goal setting, problem solving, and action planning. Enhanced self-efficacy is expected to improve adherence to dietary goals and, in turn, clinical cardio-kidney-metabolic indicators.
Aim 1 will determine the effect of INTEGRATE-CHW on behavioral outcomes. Aim 2 will examine preliminary effects on clinical outcomes. Aim 3 will evaluate implementation using mixed methods guided by RE-AIM and Proctor's framework, including semi-structured interviews with approximately 15 intervention participants and 5 staff (CHWs, registered dietitians, and clinic leads) exploring satisfaction, perceived burden, and workflow fit.
Analyses follow the intent-to-treat principle with two-sided tests (α = 0.05) and Benjamini-Hochberg false-discovery control. Between-group differences at Week 12 are estimated with analysis of covariance adjusting for baseline values. Behavioral models adjust for age, sex, language, baseline food insecurity, and CKD status. Clinical models adjust for age, sex, CKM profile, and medication classes (SGLT2 inhibitor, GLP-1 receptor agonist, ACE inhibitor/ARB, and statin use). Linear mixed-effects models are used for sensitivity analyses. Exploratory analyses test effect modification by baseline food insecurity, nutrition literacy level, and dominant CKM condition, and test whether changes in self-efficacy, literacy, or diet quality mediate changes in clinical indicators. A total of 200 participants (100 per arm) provides at least 80% power (α = 0.05) to detect a small-to-moderate effect (Cohen's d ≈ 0.35).
Studientyp
Studientyp
Einschreibung (Geschätzt)
Einschreibung
Phase
Phase
- Unzutreffend
Kontakte und Standorte
Studienkontakt
Studienkontakt
- Name: Jordan Program coordinator
- Telefonnummer: 305-348-4720
- E-Mail: joquinta@fiu.edu
Studienorte
-
-
Florida
-
Boynton Beach, Florida, Vereinigte Staaten, 33472
- Caridad Center, Inc.
-
-
Teilnahmekriterien
Zulassungskriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Adults aged 18 years or older receiving care at Caridad Center
- Documented diagnosis of type 2 diabetes (HbA1c ≥ 6.5%), hypertension (systolic blood pressure ≥ 130 mmHg), or chronic kidney disease Stages 1-4 (eGFR 15-59 mL/min/1.73 m² regardless of albuminuria, or eGFR ≥ 15 mL/min/1.73 m² with albuminuria ≥ 30 mg/g)
- Eligible for medical nutrition therapy and medically tailored groceries through -Caridad Center
- Able to provide informed consent in English or Spanish
Exclusion Criteria:
- Dialysis or advanced kidney failure (CKD Stage 5; eGFR < 15 mL/min/1.73 m²)
- Pregnancy
- Cognitive impairment precluding participation
- Plans to relocate during the 12-week intervention
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Versorgungsforschung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Single
Anzahl der Arme
Waffen und Interventionen
Teilnehmergruppe / ArmTeilnehmergruppe / Arm |
Intervention / BehandlungIntervention / Behandlung |
|---|---|
|
Experimental: INTEGRATE-CHW
Usual care plus a 12-week CHW-delivered, nutrition-focused self-management support program: six sessions of approximately 60 minutes at Weeks 1, 3, 5, 7, 9, and 11, delivered in person or virtually by participant preference, and a Week 12 wrap-up aligned with the routine dietitian visit and laboratory review. |
Trained CHWs deliver culturally tailored sessions using FlipChart visuals, pictorial goal cards, and recipe swaps. The curriculum covers diet and CKM links and home blood pressure and glucose monitoring (Session 1), diabetes (Session 2), hypertension (Session 3), CKD (Session 4), cardiometabolic integration (Session 5), and maintenance (Session 6). Participants select one to two goals from their dietitian's plan and build confidence-rated action plans. CHWs reinforce, but do not modify, dietitian guidance. Between sessions, CHWs provide reminder and follow-up contact by telephone or text message. Participants enter home blood pressure and glucose readings and goals into REDCap directly or with CHW assistance. |
|
Aktiver Komparator: Usual Care
Caridad Center standard care: individualized medical nutrition therapy from a registered dietitian approximately every three months and medically tailored groceries or meal boxes biweekly for 12 weeks. |
Individualized medical nutrition therapy from a registered dietitian following the Academy of Nutrition and Dietetics' Nutrition Care Process, plus biweekly medically tailored groceries or meal boxes for 12 weeks. |
Was misst die Studie?
Primäre Ergebnismessungen
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change From Baseline in Nutrition Self-Efficacy Scale Score at Week 12
Zeitfenster: Baseline and Week 12
|
5-item Nutrition Self-Efficacy Scale, which measures confidence in maintaining healthy eating behaviors despite common barriers. Interviewer-administered in English or Spanish. |
Baseline and Week 12
|
|
Change From Baseline in Short Food Literacy Questionnaire (SFLQ) Score at Week 12
Zeitfenster: Baseline and Week 12
|
12-item Short Food Literacy Questionnaire (SFLQ), which evaluates the ability to interpret nutrition information, read labels, and make balanced food choices. Interviewer-administered in English or Spanish. |
Baseline and Week 12
|
|
Change From Baseline in Healthy Eating Index-2020 (HEI-2020) Total Score at Week 12
Zeitfenster: Baseline and Week 12
|
Healthy Eating Index-2020 (HEI-2020) total score, derived from two 24-hour dietary recalls. |
Baseline and Week 12
|
Sekundäre Ergebnismessungen
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change From Baseline in USDA Six-Item Food Security Module Score at Week 12
Zeitfenster: Baseline and Week 12
|
USDA six-item food security module. |
Baseline and Week 12
|
|
Change From Baseline in HbA1c (%) at Week 12
Zeitfenster: Baseline and Week 12
|
Glycated hemoglobin (%), extracted from the electronic medical record. |
Baseline and Week 12
|
|
Change From Baseline in Systolic Blood Pressure (mmHg) at Week 12
Zeitfenster: Baseline and Week 12
|
Systolic blood pressure (mmHg), extracted from the electronic medical record. |
Baseline and Week 12
|
|
Change From Baseline in Diastolic Blood Pressure (mmHg) at Week 12
Zeitfenster: Baseline and Week 12
|
Diastolic blood pressure (mmHg), extracted from the electronic medical record. |
Baseline and Week 12
|
|
Change From Baseline in Body Mass Index (kg/m²) at Week 12
Zeitfenster: Baseline and Week 12
|
Body mass index (kg/m²), extracted from the electronic medical record. |
Baseline and Week 12
|
|
Change From Baseline in Lipid Profile at Week 12
Zeitfenster: Baseline and Week 12
|
Lipid profile, extracted from the electronic medical record. |
Baseline and Week 12
|
|
Change From Baseline in eGFR (mL/min/1.73 m²) at Week 12
Zeitfenster: Baseline and Week 12
|
eGFR (mL/min/1.73 m²), extracted from the electronic medical record. |
Baseline and Week 12
|
|
Change From Baseline in Urinary Albumin-to-Creatinine Ratio (mg/g) at Week 12
Zeitfenster: Baseline and Week 12
|
uACR (mg/g), extracted from the electronic medical record; log-transformed and reported as ratios of geometric means. |
Baseline and Week 12
|
Andere Ergebnismessungen
Andere Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Feasibility: Proportion of Eligible Patients Who Enroll and Complete Follow-up
Zeitfenster: Enrollment through Week 12 follow-up
|
Proportion of eligible patients who enroll and complete follow-up. |
Enrollment through Week 12 follow-up
|
|
Reach: Demographic Comparability of Enrolled Participants With the Clinic's CKM Population
Zeitfenster: Enrollment period
|
Demographic comparability between enrolled participants and the clinic's CKM population. |
Enrollment period
|
|
Fidelity: Percentage of CHW Sessions Meeting All Required Elements
Zeitfenster: Weeks 1-12
|
Percentage of CHW sessions meeting all required elements, assessed through CHW session checklists, direct observation, and periodic audio review. |
Weeks 1-12
|
|
Acceptability: Theoretical Framework of Acceptability (TFA) Survey Score
Zeitfenster: Week 12
|
Theoretical Framework of Acceptability (TFA) survey completed by intervention participants. |
Week 12
|
|
Adoption: Proportion of RDs, CHWs, and Food Partners Delivering the Program as Intended
Zeitfenster: Up to 21 months (intervention delivery period)
|
Proportion of participating registered dietitians, CHWs, and food partners delivering the program as intended. |
Up to 21 months (intervention delivery period)
|
|
Incremental Cost per Participant (US Dollars)
Zeitfenster: 12 weeks
|
Estimated from staff time, session duration, and supply costs, with cost per unit outcome. |
12 weeks
|
Mitarbeiter und Ermittler
Sponsor
Sponsor
Mitarbeiter
Mitarbeiter
Ermittler
Ermittler
- Hauptermittler: Janet Diaz Martinez, Florida International University
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Geschätzt)
Studienbeginn
Primärer Abschluss (Geschätzt)
Primärer Abschluss
Studienabschluss (Geschätzt)
Studienabschluss
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Zuerst gepostet
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes Update gepostet
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
- Urogenitale Erkrankungen
- Erkrankungen des endokrinen Systems
- Gefäßerkrankungen
- Herz-Kreislauf-Erkrankungen
- Pathologische Prozesse
- Männliche Urogenitalerkrankungen
- Nierenerkrankungen
- Urologische Erkrankungen
- Weibliche Urogenitalerkrankungen
- Weibliche Urogenitalerkrankungen und Schwangerschaftskomplikationen
- Herzkrankheiten
- Chronische Erkrankung
- Krankheitsattribute
- Stoffwechselerkrankungen
- Störungen des Glukosestoffwechsels
- Diabetes Mellitus
- Niereninsuffizienz
- Herzfehler
- Pathologische Zustände, Anzeichen und Symptome
- Ernährungs- und Stoffwechselerkrankungen
- Hypertonie
- Diabetes mellitus, Typ 2
- Niereninsuffizienz, chronisch
- Kardio-renales Syndrom
Andere Studien-ID-Nummern
Andere Studien-ID-Nummern
- IRB-26-0430
- 2027-68015-47755 (Andere Zuschuss-/Finanzierungsnummer: USDA National Institute of Food and Agriculture)
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Beschreibung des IPD-Plans
Following publication of primary findings, de-identified datasets, data dictionaries, and codebooks will be made available through FIU's secure repository. Shared files will exclude personally identifiable information and contain only derived variables.
IPD-Sharing-Zeitrahmen
Following publication of primary findings; data will remain available for at least five years after project completion or publication of final results, whichever occurs later.
IPD-Sharing-Zugriffskriterien
De-identified datasets, data dictionaries, codebooks, and analytic code will be available to researchers through FIU's institutional repository and, where applicable, the USDA Ag Data Commons, under FIU's Open Data Policy for research and educational re-use with attribution. Shared files will exclude personally identifiable information and contain only derived variables. Requests for restricted materials, such as qualitative transcripts, will require a data-use agreement and ethics approval.
Art der unterstützenden IPD-Freigabeinformationen
- ANALYTIC_CODE
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .